Jennifer K. Simpson
Insider Reports History
- Location
- New York, NY
- Signature
- /s/ Joshua L. Colburn, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Jennifer K. Simpson:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Panbela Therapeutics, Inc. | President and CEO, Director | Stock Option (right to buy) | 72,800 | 01 Oct 2024 | Direct | ||
| EAGLE PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 16,253 | 07 Mar 2023 | Direct | ||
| LadRx Corp | Director | Stock Option (Right to Buy) | 5,000 | 15 Jan 2024 | Direct |
Insider Reports Filed by Jennifer K. Simpson
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PBLA | Panbela Therapeutics, Inc. | 01 Oct 2024 | 1 | $0 | 4 | President and CEO, Director | 03 Oct 2024, 16:25 |
| LADX | LadRx Corp | 15 Jan 2024 | 1 | $0 | 4 | Director | 29 Jan 2024, 16:05 |
| PBLA | Panbela Therapeutics, Inc. | 27 Mar 2023 | 1 | $0 | 4 | President and CEO, Director | 29 Mar 2023, 16:26 |
| EGRX | EAGLE PHARMACEUTICALS, INC. | 07 Mar 2023 | 1 | $0 | 4 | Director | 09 Mar 2023, 20:02 |
| PBLA | Panbela Therapeutics, Inc. | 30 Jan 2023 | 2 | $0 | 4 | President and CEO, Director | 01 Feb 2023, 15:37 |
| EGRX | EAGLE PHARMACEUTICALS, INC. | 28 Feb 2022 | 1 | $0 | 4 | Director | 02 Mar 2022, 17:05 |
| LADX | CYTRX CORP | 15 Dec 2021 | 1 | $0 | 4/A | Director | 11 Jan 2022, 20:35 |
| LADX | CYTRX CORP | 15 Dec 2021 | 1 | $0 | 4 | Director | 17 Dec 2021, 09:08 |
| PBLA | Panbela Therapeutics, Inc. | 13 Sep 2021 | 1 | $0 | 4 | President and CEO, Director | 15 Sep 2021, 18:00 |
| LADX | CYTRX CORP | 29 Jul 2021 | 0 | $0 | 3 | Director | 11 Aug 2021, 19:24 |